英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
boneheaded查看　boneheaded　在百度字典中的解释百度英翻中〔查看〕
boneheaded查看　boneheaded　在Google字典中的解释Google英翻中〔查看〕
boneheaded查看　boneheaded　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • | About LaboFlex
    Our Philosophy LaboFlex is dedicated to researching and developing scientific formulated, plant-based trusted products that provide soothing and safe solutions since 1992
  • 管理联系人 - 来发信
    一、界面预览 界面预览 1️⃣ 选择联系人前 ; 选择联系人前的界面 1️⃣ 选择区域：可以勾选选择想要管理的联系人; 2️⃣ 筛选与搜索：可以通过邮箱验证结果和联系人标签筛选，也可通过关键词搜索联系人。; 3️⃣ 功能区域：新建联系人 、导入联系人、群发邮件、验证邮箱 、导出联系人
  • Lithium iron(II) phosphate - 98% prefix CAS No. 15365-14-7 | Aladdin . . .
    Order Lithium iron(II) phosphate with 98% Ideal for , this reagent supports Store at Room temperature,Argon charged,Desiccated For use within Available now at Aladdin Scientific
  • Long-Acting Injectables (LAI) for Mental Health Addiction Recovery . . .
    At Midwest Recovery Centers, our LAI Clinic offers a reliable alternative to daily pills through long acting injectables treatments This service is for people who struggle with daily tablets, capsules, or liquids and are seeking effective ways to get over mental health issues Our caring team creates a safe space for patients to receive regular medication support, ensuring they have what they
  • FDA approves tafasitamab-cxix for relapsed or refractory follicular . . .
    On June 18, 2025, the Food and Drug Administration approved tafasitamab-cxix (Monjuvi, Incyte Corporation) with lenalidomide and rituximab for adults with relapsed or refractory follicular
  • News Release - Eli Lilly and Company
    INDIANAPOLIS, June 13, 2022 PRNewswire -- Eli Lilly and Company (NYSE: LLY) and Incyte (NASDAQ:INCY) announced today that the U S Food and Drug Administration (FDA) has approved OLUMIANT ® (baricitinib), a once-daily pill, as a first-in-disease systemic treatment for adults with severe alopecia areata (AA), available as 4-mg, 2-mg and 1-mg tablets 1 The recommended dose is OLUMIANT 2-mg
  • Combating oxi-inflamm-aging: Passerini adducts tethered with 1,2,3 . . .
    Concurrently, several reports have clearly demonstrated the impact of the 1,2,3-triazole motif in enhancing the 5-lipoxygenase inhibitory activity as shown in compound III (IC 50 = 24 μM) 26,27 Furthermore, the 1,2,3-triazole tethered indole-3-glyoxamide, IV, displayed potent inhibitory activity against 5-LOX (IC 50 = 7 73 μM) and its docking study demonstrated the involvement of the
  • Health Canada Licenses XEOMIN ® (incobotulinumtoxinA) for Adult . . .
    Merz Therapeutics announced Health Canada’s notice of compliance for XEOMIN® (incobotulinumtoxinA) for the treatment of chronic sialorrhea in adults
  • Lipoxin A4 - MilliporeSigma
    Lipoxin A4 Lipoxin A₄, CAS 89663-86-5, is a potent inhibitor of cytotoxic activity of human natural killer cells Shown to be as potent as LTB4 in stimulating human neutrophils to generate superoxides ; CAS Number: 89663-86-5; Synonyms: Lipoxin A4,LXA₄, 5(S),6(R),15(S)-Trihydroxyeicosa-7- trans-9- trans-11- cis-13- trans-tetraenoic Acid,LXA₄, 5(S),6(R),15(S)-Trihydroxyeicosa-7-trans-9
  • RyboDyn Joins Lilly Gateway Labs to Advance Immunotherapies Targeting . . .
    RyboDyn, Inc , a biotechnology company pioneering first-in-class immunotherapies targeting the dark proteome, announced its selection to join Lilly Gateway Labs (LGL) in San Diego, an innovation hub operated with Alexandria […]





中文字典-英文字典  2005-2009